| 000 | 01281 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250514194850.0 | ||
| 264 | 0 | _c20040907 | |
| 008 | 200409s 0 0 ger d | ||
| 022 | _a0033-832X | ||
| 024 | 7 |
_a10.1007/s00117-004-1026-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aReimer, P | |
| 245 | 0 | 0 |
_a[Contrast agents in MRT. Substance, effects, pharmacology and validity]. _h[electronic resource] |
| 260 |
_bDer Radiologe _cMar 2004 |
||
| 300 |
_a273-83 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnaphylaxis _xchemically induced |
| 650 | 0 | 4 |
_aChelating Agents _xadverse effects |
| 650 | 0 | 4 |
_aContrast Media _xadministration & dosage |
| 650 | 0 | 4 |
_aDrug Hypersensitivity _xetiology |
| 650 | 0 | 4 |
_aFerric Compounds _xadverse effects |
| 650 | 0 | 4 |
_aGadolinium _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aMagnetic Resonance Imaging _xadverse effects |
| 650 | 0 | 4 | _aMagnetics |
| 650 | 0 | 4 |
_aPatient Care Management _xmethods |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 700 | 1 | _aVosshenrich, R | |
| 773 | 0 |
_tDer Radiologe _gvol. 44 _gno. 3 _gp. 273-83 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00117-004-1026-8 _zAvailable from publisher's website |
| 999 |
_c14988421 _d14988421 |
||